CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Hepatic and Cardiovascular endpoints for patients with Type 2 Diabetes who are inadequately controlled with insulin therapy. The purpose of ...
Louisville, Kentucky, United States and 62 other locations
preserving beta-cell function and delaying the progression of type 1 diabetes (T1D) in adolescent and adult patients. The safety of ladarixi...
Phase 3
Louisville, Kentucky, United States and 56 other locations
double-blind, placebo-controlled study of HTD1801 in adult subjects with non-alcoholic steatohepatitis and liver fibrosis who have type 2 diabetes...
Phase 2
Louisville, Kentucky, United States and 54 other locations
This study will look at the long-term effects of semaglutide (active medicine) on diabetic eye disease when compared to placebo (dummy medic...
Phase 3
Louisville, Kentucky, United States and 173 other locations
The purpose of the trial is to assess the efficacy and safety of tirzepatide to dulaglutide in participants with type 2 diabetes and increas...
Phase 3
Louisville, Kentucky, United States and 636 other locations
it takes the body to remove it in pediatric participants with Type 2 Diabetes Mellitus (T2DM). The study will last for approximately 100 day...
Phase 1
Louisville, Kentucky, United States and 9 other locations
This study compares 2 medicines for type 2 diabetes: semaglutide (new medicine) and a dummy medicine (placebo). Semaglutide will be tested t...
Phase 3
Louisville, Kentucky, United States and 87 other locations
The researchers are doing this study to look whether the type 2 diabetes medicine, semaglutide, has a positive effect on heart disease. Part...
Phase 3
Louisville, Kentucky, United States and 467 other locations
The reason for this study is to see if the study drug insulin efsitora alfa (LY3209590) is safe and effective in participants with Type 2 diabetes...
Phase 3
Louisville, Kentucky, United States and 118 other locations
in combination with a basal insulin (i.e., the Rapid-acting Insulin Analog [RAA] injection group) in pediatric subjects with type 1 or type 2 diabetes...
Phase 3
Louisville, Kentucky, United States and 39 other locations
Clinical trials
Research sites
Resources
Legal